Restaging magnetic resonance imaging of the rectum after neoadjuvant therapy: a practical guide

Natally Horvat,João Miranda,Fernanda Kinochita,Tiago Lins de Carvalho,Giovanni Brondani Torri,Thiago José Pinheiro Lopes,Cesar Higa Nomura
DOI: https://doi.org/10.1590/0100-3984.2024.0004
2024-07-16
Abstract:Colorectal cancer is the third most common cancer and the second leading cause of cancer-related death. Rectal cancer accounts for approximately one-third of new colorectal cancer cases, with adenocarcinoma as the predominant subtype. Despite an overall decline in colorectal cancer incidence and mortality, due to advancements in screening, early diagnosis, and treatment options, there is a concerning increase in incidence rates among young patients. Recent significant advances in managing locally advanced rectal cancer, such as the establishment of different surgical approaches, neoadjuvant treatment using different protocols for high-risk cases, and the adoption of organ-preservation strategies, have increased the importance of the role played by radiologists in locoregional assessment on magnetic resonance imaging at baseline, at restaging, and during active surveillance of patients with rectal cancer. In this article, we review the role of restaging rectal magnetic resonance imaging after neoadjuvant therapy, providing radiologists with a practical, step-by-step guide for assessing treatment response.
What problem does this paper attempt to address?